Submitted:
01 April 2026
Posted:
03 April 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results
3.1. Descriptive Statistics
3.2. DASS-21 Clinical Severity Distribution
3.3. Temporal Stability: Paired Comparisons
3.4. Internal Consistency
3.5. Mediation Analysis
3.6. Hierarchical Regression
3.7. DASS-21 Clinical Severity and Quality of Life
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| ACT | Acceptance and Commitment Therapy |
| BC | Breast Cancer |
| PI | Psychological Inflexibility |
| QoL | Quality of Life |
Appendix A
| Measure | Time | n | M | SD | Mdn | Skew | Kurt | SW p |
|---|---|---|---|---|---|---|---|---|
| AAQ-II | M0 | 40 | 17.35 | 9.32 | 17.00 | 0.61 | -0.76 | .003 |
| AAQ-II | M2 | 40 | 15.95 | 7.71 | 14.00 | 0.60 | -0.77 | .004 |
| DASS Depression | M0 | 40 | 4.08 | 5.32 | 2.00 | 1.30 | 0.69 | <.001 |
| DASS Depression | M2 | 40 | 3.35 | 5.13 | 1.00 | 1.89 | 2.99 | <.001 |
| DASS Anxiety | M0 | 39 | 4.03 | 4.75 | 3.00 | 1.34 | 1.47 | <.001 |
| DASS Anxiety | M2 | 40 | 3.75 | 4.93 | 1.50 | 1.64 | 2.36 | <.001 |
| DASS Stress | M0 | 39 | 5.74 | 5.14 | 5.00 | 0.90 | -0.26 | .001 |
| DASS Stress | M2 | 40 | 4.70 | 4.25 | 4.50 | 1.50 | 3.48 | <.001 |
| QoL Physical | M0 | 40 | 62.77 | 20.04 | 64.29 | 0.06 | -0.80 | .395 |
| QoL Physical | M2 | 40 | 66.34 | 17.86 | 69.64 | -0.18 | -0.91 | .331 |
| QoL Psychological | M0 | 40 | 69.48 | 19.11 | 70.83 | -0.23 | -1.00 | .213 |
| QoL Psychological | M2 | 40 | 70.52 | 18.40 | 75.00 | -0.76 | -0.19 | .016 |
| QoL Social | M0 | 40 | 68.54 | 15.84 | 75.00 | -0.47 | -0.27 | .042 |
| QoL Social | M2 | 40 | 67.50 | 17.38 | 66.67 | -0.29 | -0.73 | .147 |
| QoL Environmental | M0 | 39 | 63.46 | 16.97 | 62.50 | 0.33 | -0.65 | .359 |
| QoL Environmental | M2 | 40 | 63.28 | 17.97 | 65.62 | 0.11 | -0.63 | .450 |
| QoL General | M0 | 40 | 61.88 | 15.75 | 62.50 | -0.36 | -0.78 | .008 |
| QoL General | M2 | 40 | 63.75 | 15.45 | 62.50 | -0.18 | -0.28 | .008 |
| Subscale | Time | Normal | Mild | Moderate | Severe | Ext. Severe |
|---|---|---|---|---|---|---|
| Depression | M0 | 28 (70.0%) | 2 (5.0%) | 5 (12.5%) | 2 (5.0%) | 3 (7.5%) |
| Depression | M2 | 29 (72.5%) | 3 (7.5%) | 4 (10.0%) | 1 (2.5%) | 3 (7.5%) |
| Anxiety | M0 | 22 (56.4%) | 6 (15.4%) | 3 (7.7%) | 3 (7.7%) | 5 (12.8%) |
| Anxiety | M2 | 26 (65.0%) | 4 (10.0%) | 3 (7.5%) | 2 (5.0%) | 5 (12.5%) |
| Stress | M0 | 27 (69.2%) | 4 (10.3%) | 3 (7.7%) | 3 (7.7%) | 2 (5.1%) |
| Stress | M2 | 34 (85.0%) | 2 (5.0%) | 2 (5.0%) | 1 (2.5%) | 1 (2.5%) |
| Measure | M (M0) | M (M2) | Δ | Test | p | d | Sig |
|---|---|---|---|---|---|---|---|
| AAQ-II | 17.35 | 15.95 | -1.40 | Wilcoxon | .493 | -0.20 | ns |
| DASS Depression | 4.08 | 3.35 | -0.72 | Wilcoxon | .423 | -0.16 | ns |
| DASS Anxiety | 4.03 | 3.72 | -0.31 | Wilcoxon | .957 | -0.07 | ns |
| DASS Stress | 5.74 | 4.59 | -1.15 | Wilcoxon | .126 | -0.28 | ns |
| QoL Physical | 62.77 | 66.34 | 3.57 | Paired t | .103 | 0.26 | ns |
| QoL Psychological | 69.48 | 70.52 | 1.04 | Wilcoxon | .843 | 0.08 | ns |
| QoL Social | 68.54 | 67.50 | -1.04 | Wilcoxon | .500 | -0.09 | ns |
| QoL Environmental | 63.46 | 63.70 | 0.24 | Paired t | .882 | 0.02 | ns |
| QoL General | 61.88 | 63.75 | 1.88 | Wilcoxon | .409 | 0.15 | ns |
| Timepoint | Mediator | Outcome | Indirect [95% CI] | p | Direct | Total | % Med |
|---|---|---|---|---|---|---|---|
| Baseline (M0) | Depression | Physical | -0.133 [-1.07, 0.17] | .513 | -1.25 | -1.39 | 9.6% |
| Depression | Psychological | 0.025 [-0.40, 0.33] | .874 | -1.67 | -1.64 | -1.5% | |
| Depression | General | 0.200 [-0.34, 0.41] | .297 | -1.56 | -1.36 | -14.7% | |
| Anxiety | Physical | -0.151 [-1.07, 0.08] | .370 | -1.25 | -1.40 | 10.8% | |
| Anxiety | Psychological | -0.010 [-0.72, 0.16] | .903 | -1.68 | -1.69 | 0.6% | |
| Anxiety | General | 0.186 [-0.41, 0.33] | .316 | -1.59 | -1.40 | -13.3% | |
| Stress | Physical | 0.096 [-0.50, 0.46] | .673 | -1.49 | -1.39 | -6.9% | |
| Stress | Psychological | 0.227 [-0.08, 0.61] | .156 | -1.87 | -1.64 | -13.8% | |
| Stress | General | 0.301 [-0.08, 0.55] | .092 | -1.66 | -1.36 | -22.1% | |
| Follow-up (M2) | Depression | Physical | -0.661 [-1.20, -0.32]* | .002 | -0.79 | -1.45 | 45.7% |
| Depression | Psychological | -0.845 [-1.45, -0.37]* | <.001 | -0.93 | -1.77 | 47.7% | |
| Depression | General | -0.573 [-1.03, -0.13]* | .009 | -0.71 | -1.29 | 44.5% | |
| Anxiety | Physical | -0.739 [-1.36, -0.50]* | <.001 | -0.71 | -1.45 | 51.1% | |
| Anxiety | Psychological | -0.830 [-1.43, -0.26]* | .007 | -0.94 | -1.77 | 46.9% | |
| Anxiety | General | -0.551 [-1.00, -0.07]* | .023 | -0.74 | -1.29 | 42.8% | |
| Stress | Physical | -0.474 [-0.89, -0.11]* | .022 | -0.97 | -1.45 | 32.8% | |
| Stress | Psychological | -0.723 [-1.20, -0.18]* | .005 | -1.05 | -1.77 | 40.8% | |
| Stress | General | -0.628 [-0.99, -0.17]* | .008 | -0.66 | -1.29 | 48.8% | |
| Change (Δ) | Depression | Physical | -0.126 [-0.53, 0.12] | .480 | -0.08 | -0.20 | 61.6% |
| Depression | Psychological | -0.133 [-0.64, 0.06] | .468 | -0.46 | -0.59 | 22.4% | |
| Depression | General | -0.084 [-0.63, 0.02] | .405 | -0.52 | -0.60 | 13.9% | |
| Anxiety | Physical | -0.035 [-0.33, 0.28] | .812 | -0.15 | -0.18 | 19.5% | |
| Anxiety | Psychological | -0.035 [-0.35, 0.19] | .817 | -0.58 | -0.61 | 5.6% | |
| Anxiety | General | -0.028 [-0.34, 0.12] | .768 | -0.60 | -0.63 | 4.4% | |
| Stress | Physical | -0.059 [-0.35, 0.09] | .545 | -0.16 | -0.22 | 26.9% | |
| Stress | Psychological | -0.037 [-0.17, 0.12] | .776 | -0.57 | -0.61 | 6.1% | |
| Stress | General | -0.037 [-0.24, 0.08] | .696 | -0.56 | -0.60 | 6.2% |
| Outcome | R² S1 | R² S2 | ΔR² | AAQ M2 (S2) | R² S3 | AAQ M2 (S3) | AAQ M0 (S3) |
|---|---|---|---|---|---|---|---|
| QoL Psychological | .606 | .700 | .094 | -.97** | .703 | -.91** | -.18 |
| QoL Social | .603 | .609 | .006 | -.23 | .609 | -.21 | -.07 |
| QoL Environmental | .698 | .729 | .031 | -.51† | .735 | -.64* | .24 |
| QoL General | .438 | .522 | .084 | -.75* | .523 | -.71* | -.10 |
| DASS Anxiety | .416 | .538 | .122 | .26** | .593 | .15 | .20* |
| DASS | QoL Domain | H | df | p | p (adj) | Sig |
|---|---|---|---|---|---|---|
| Anxiety | Physical | 14.99 | 4 | .005 | .016 | * |
| Anxiety | Psychological | 15.49 | 4 | .004 | .016 | * |
| Anxiety | Social | 20.41 | 4 | <.001 | .006 | ** |
| Anxiety | Environmental | 11.03 | 4 | .026 | .049 | * |
| Anxiety | General | 14.11 | 4 | .007 | .017 | * |
| Depression | Physical | 11.84 | 4 | .019 | .040 | * |
| Depression | Psychological | 9.70 | 4 | .046 | .076 | ns |
| Depression | Social | 16.67 | 4 | .002 | .016 | * |
| Depression | Environmental | 4.33 | 4 | .363 | .411 | ns |
| Depression | General | 7.67 | 4 | .104 | .156 | ns |
| Stress | Physical | 6.21 | 4 | .184 | .251 | ns |
| Stress | Psychological | 5.31 | 4 | .257 | .321 | ns |
| Stress | Social | 14.66 | 4 | .005 | .016 | * |
| Stress | Environmental | 4.17 | 4 | .384 | .411 | ns |
| Stress | General | 3.75 | 4 | .441 | .441 | ns |
References
- Bray, F; Laversanne, M; Sung, H; Ferlay, J; Siegel, RL; Soerjomataram, I; et al. Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2024, 74(3), 229–263. [Google Scholar] [CrossRef] [PubMed]
- Penberthy, JK; Stewart, AL; Centeno, CF; Penberthy, DR. Psychological Aspects of Breast Cancer. Psychiatr Clin North Am. 2023, 46(3), 551–570. [Google Scholar] [CrossRef] [PubMed]
- Carreira, H; Williams, R; Müller, M; Harewood, R; Stanway, S; Bhaskaran, K. Associations between Breast Cancer Survivorship and Adverse Mental Health Outcomes: A Systematic Review. J Natl Cancer Inst. 2018, 110(12), 1311–1327. [Google Scholar] [CrossRef]
- Wang, YH; Li, JQ; Shi, JF; Que, JY; Liu, JJ; Lappin, JM; et al. Depression and Anxiety in Relation to Cancer Incidence and Mortality: A Systematic Review and Meta-Analysis of Cohort Studies. Mol Psychiatry 2020, 25(7), 1487–1499. [Google Scholar] [CrossRef]
- Mitchell, AJ; Chan, M; Bhatti, H; Halton, M; Grassi, L; Johansen, C; et al. Prevalence of Depression, Anxiety, and Adjustment Disorder in Oncological, Haematological, and Palliative-Care Settings: A Meta-Analysis of 94 Interview-Based Studies. Lancet Oncol. 2011, 12(2), 160–174. [Google Scholar] [CrossRef]
- Hayes, SC; Strosahl, KD; Wilson, KG. Acceptance and Commitment Therapy: The Process and Practice of Mindful Change, 2nd Ed ed; Guilford Press: New York, 2012. [Google Scholar]
- Bond, FW; Hayes, SC; Baer, RA; Carpenter, KM; Guenole, N; Orcutt, HK; et al. Preliminary Psychometric Properties of the Acceptance and Action Questionnaire-II: A Revised Measure of Psychological Inflexibility and Experiential Avoidance. Behav Ther. 2011, 42(4), 676–688. [Google Scholar] [CrossRef]
- Zhang, CQ; Leeming, E; Smith, P; Chung, PK; Hagger, MS; Hayes, SC. Acceptance and Commitment Therapy for Health Behavior Change: A Contextually-Driven Approach. Front Psychol. 2018, 8, 2350. [Google Scholar] [CrossRef]
- Fashler, SR; Weinrib, AZ; Azam, MA; Katz, J. The Use of Acceptance and Commitment Therapy in Oncology Settings: A Narrative Review. Psychol Rep. 2018, 121(2), 229–252. [Google Scholar] [CrossRef]
- Li, H; Wu, J; Ni, Q; Zhang, J; Wang, Y; He, G. Systematic Review and Meta-Analysis of Effectiveness of Acceptance and Commitment Therapy in Patients with Breast Cancer. Nurs Res. 2021, 70(4), E152–E160. [Google Scholar] [CrossRef]
- Johns, SA; Stutz, PV; Talib, TL; Cohee, AA; Beck-Coon, KA; Brown, LF; et al. Acceptance and Commitment Therapy for Breast Cancer Survivors with Fear of Cancer Recurrence: A 3-Arm Pilot Randomized Controlled Trial. Cancer 2020, 126(1), 211–218. [Google Scholar] [CrossRef] [PubMed]
- Ghorbani, V; Zanjani, Z; Omidi, A; Sarvizadeh, M. Efficacy of Acceptance and Commitment Therapy on Depression, Pain Acceptance, and Psychological Flexibility in Married Women with Breast Cancer: A Pre- and Post-Test Clinical Trial. Trends Psychiatry Psychother. 2021, 43(2), 126–133. [Google Scholar] [CrossRef]
- Yela, JR; Gómez-Martínez, MÁ; Crego, A; Jiménez-García, C. Reductions in Experiential Avoidance Explain Changes in Anxiety, Depression and Well-Being after a Mindfulness and Self-Compassion (MSC) Training. Psychol Psychother. 2022, 95(1), 72–86. [Google Scholar] [CrossRef] [PubMed]
- Mohammadkhani, P; Forouzan, AS; Hooshyari, Z; Abasi, I. The Role of Neuroticism and Experiential Avoidance in Predicting Anxiety and Depression Symptoms: Mediating Role of Emotion Regulation. Iran J Psychiatry Behav Sci. 2016, 10(3), E5047. [Google Scholar] [CrossRef]
- Klimczak, KS; San Miguel, GG; Mukasa, MN; Twohig, MP; Levin, ME. A Systematic Review and Meta-Analysis of Self-Guided Online Acceptance and Commitment Therapy as a Transdiagnostic Self-Help Intervention. Cogn Behav Ther. 2023, 52(3), 269–294. [Google Scholar] [CrossRef]
- Trindade, IA; Marta-Simões, J; Mendes, AL; Borrego, M; Ponte, A; Carvalho, C; et al. A Longitudinal Preliminary Analysis on the Role of Experiential Avoidance in Breast Cancer Patients’ Reported Health Outcomes. Psychooncology 2020, 29(4), 812–814. [Google Scholar] [CrossRef] [PubMed]
- Trindade, IA. Experiential Avoidance and Breast Cancer [Dataset]. In Mendeley Data; 2019. [Google Scholar] [CrossRef]
- Lovibond, SH; Lovibond, PF. Manual for the Depression Anxiety Stress Scales, 2nd Ed ed; Psychology Foundation of Australia: Sydney, 1995. [Google Scholar]
- The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. Psychol Med. 1998, 28(3), 551–558. [Google Scholar] [CrossRef]
- Akbari, M; Seydavi, M; Hosseini, ZS; Krafft, J; Levin, ME. Experiential Avoidance in Depression, Anxiety, Obsessive-Compulsive Related, and Posttraumatic Stress Disorders: A Comprehensive Systematic Review and Meta-Analysis. J Context Behav Sci. 2022, 24, 65–78. [Google Scholar] [CrossRef]
- Al-Abbadey, M; Tomescu-Stachie, S; Kaklamanou, D; Jarrett, N; Merwood, A; Tyndall, I; et al. The Role of Psychological Flexibility in Relation to Health Outcomes in People in Remission from Cancer. Br J Health Psychol. 2025, 30(3), E12807. [Google Scholar] [CrossRef]
- Tingley, D; Yamamoto, T; Hirose, K; Keele, L; Imai, K. Mediation: R Package for Causal Mediation Analysis. J Stat Softw. 2014, 59(5), 1–38. [Google Scholar] [CrossRef]
- Fritz, MS; MacKinnon, DP. Required Sample Size to Detect the Mediated Effect. Psychol Sci. 2007, 18(3), 233–239. [Google Scholar] [CrossRef]
- Donahue, ML; Levin, ME; Olson, K; Panza, E; Lillis, J. Examining the Role of Experiential Avoidance and Valued Action in the Negative Effects of Weight Self-Stigma. J Behav Med. 2023, 46(3), 517–524. [Google Scholar] [CrossRef]
- Bardeen, JR; Fergus, TA; Orcutt, HK. Experiential Avoidance as a Moderator of the Relationship between Anxiety Sensitivity and Perceived Stress. Behav Ther. 2013, 44(3), 459–469. [Google Scholar] [CrossRef]
- Panjwani, AA; Applebaum, AJ; Revenson, TA; Erblich, J; Rosenfeld, B. Intolerance of Uncertainty, Experiential Avoidance, and Trust in Physician: A Moderated Mediation Analysis of Emotional Distress in Advanced Cancer. J Behav Med. 2024, 47(1), 71–81. [Google Scholar] [CrossRef]
- Kashdan, TB; Morina, N; Priebe, S. Post-Traumatic Stress Disorder, Social Anxiety Disorder, and Depression in Survivors of the Kosovo War: Experiential Avoidance as a Contributor to Distress and Quality of Life. J Anxiety Disord. 2009, 23(2), 185–196. [Google Scholar] [CrossRef]
- Bullock, JG; Green, DP; Ha, SE. Yes, but What’s the Mechanism? (Don’t Expect an Easy Answer). J Pers Soc Psychol. 2010, 98(4), 550–558. [Google Scholar] [CrossRef] [PubMed]
- Stein, AT; Medina, JL; Rosenfield, D; Otto, MW; Smits, JAJ. Examining Experiential Avoidance as a Mediator of the Relation between Anxiety Sensitivity and Depressive Symptoms. Cogn Behav Ther. 2019, 49(1), 41–54. [Google Scholar] [CrossRef]
- Burgess, C; Cornelius, V; Love, S; Graham, J; Richards, M; Ramirez, A. Depression and Anxiety in Women with Early Breast Cancer: Five Year Observational Cohort Study. BMJ 2005, 330(7493), 702. [Google Scholar] [CrossRef] [PubMed]
- Lim, CC; Devi, MK; Ang, E. Anxiety in Women with Breast Cancer Undergoing Treatment: A Systematic Review. Int J Evid Based Healthc. 2011, 9(3), 215–235. [Google Scholar] [PubMed]
- Hughes, S; Jaremka, LM; Alfano, CM; Glaser, R; Povoski, SP; Lipari, AM; et al. Social Support Predicts Inflammation, Pain, and Depressive Symptoms: Longitudinal Relationships among Breast Cancer Survivors. Psychoneuroendocrinology 2014, 42, 38–44. [Google Scholar] [CrossRef]
- Marinkovic, M; Djordjevic, N; Djordjevic, L; Ignjatovic, N; Djordjevic, M; Karanikolic, V. Assessment of the Quality of Life in Breast Cancer Depending on the Surgical Treatment. Support Care Cancer 2021, 29(6), 3257–3266. [Google Scholar] [CrossRef]
- Simard, S; Thewes, B; Humphris, G; Dixon, M; Hayden, C; Mireskandari, S; et al. Fear of Cancer Recurrence in Adult Cancer Survivors: A Systematic Review of Quantitative Studies. J Cancer Surviv. 2013, 7(3), 300–322. [Google Scholar] [CrossRef]
- Brunault, P; Toledano, A; Aguerre, C; Suzanne, I; Garaud, P; Trzepidur-Edom, M; et al. Impact of Late Treatment-Related Radiotherapy Toxicity, Depression, and Anxiety on Quality of Life in Long-Term Breast Cancer Survivors. Bull Cancer 2012, 99(5), 589–598. [Google Scholar] [CrossRef]
- Riba, MB; Donovan, KA; Andersen, B; Braun, I; Breitbart, WS; Brewer, BW; et al. Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019, 17(10), 1229–1249. [Google Scholar] [CrossRef] [PubMed]
- Graham, CD; Gouick, J; Kravariti, E; Gillanders, D. A Systematic Review of the Use of Acceptance and Commitment Therapy (ACT) in Chronic Disease and Long-Term Conditions. Clin Psychol Rev. 2016, 46, 46–58. [Google Scholar] [CrossRef]
- Gonzalez-Fernandez, S; Fernandez-Rodriguez, C. Acceptance and Commitment Therapy in Cancer: Review of Applications and Findings. Behav Med. 2019, 45(3), 255–269. [Google Scholar] [CrossRef] [PubMed]
- MacKinnon, DP; Fairchild, AJ; Fritz, MS. Mediation Analysis. Annu Rev Psychol. 2007, 58, 593–614. [Google Scholar] [CrossRef]
- Hayes, AF. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach, 3rd Ed ed; Guilford Press: New York, 2022. [Google Scholar]
- Cheng, HG; Phillips, MR. Secondary Analysis of Existing Data: Opportunities and Implementation. Shanghai Arch Psychiatry 2014, 26(6), 371–375. [Google Scholar]
- Doolan, DM; Froelicher, ES. Using an Existing Data Set to Answer New Research Questions: A Methodological Review. Res Theory Nurs Pract. 2009, 23(3), 203–215. [Google Scholar] [CrossRef] [PubMed]
- Hulbert-Williams, NJ; Storey, L; Wilson, KG. Psychological Interventions for Patients with Cancer: Psychological Flexibility and the Potential Utility of Acceptance and Commitment Therapy. Eur J Cancer Care 2015, 24(1), 15–27. [Google Scholar] [CrossRef]





Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).